Genmab A/S
GMAB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001434265
No open-market purchases or sales by Genmab A/S insiders were filed in the last 90 days; 291 institutions reported holding it in 13F filings for Q2 2026, worth $2.81B in total; no superinvestor holds it.
Other share classesGNMSF
13F holders, Q2 2023
Institutional positions in Genmab A/S as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 214
- −3 vs. Q1 2023
- Shares held
- 41.7M
- −1.88M (−4.3%) vs. Q1 2023
- Total value
- $1.59B
- −$35.9M (−2.2%) vs. Q1 2023
- New holders
- 29
- 71 more added
- Sold out
- 32
- 82 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GMAB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 291 | $2.81B |
| Q1 2026 | 275 | $2.23B |
| Q4 2025 | 293 | $2.26B |
| Q3 2025 | 253 | $1.89B |
| Q2 2025 | 218 | $1.32B |
| Q1 2025 | 220 | $1.27B |
| Q4 2024 | 230 | $1.27B |
| Q3 2024 | 224 | $1.27B |
| Q2 2024 | 220 | $1.23B |
| Q1 2024 | 227 | $1.43B |
| Q4 2023 | 226 | $1.48B |
| Q3 2023 | 234 | $1.67B |
| Q2 2023 | 214 | $1.59B |
| Q1 2023 | 217 | $1.62B |
| Q4 2022 | 238 | $1.94B |
| Q3 2022 | 194 | $1.43B |
| Q2 2022 | 181 | $1.15B |
| Q1 2022 | 204 | $1.41B |
| Q4 2021 | 212 | $1.58B |
| Q3 2021 | 213 | $1.89B |
| Q2 2021 | 213 | $1.89B |
| Q1 2021 | 211 | $1.37B |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Genmab A/S; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 636,381 | $24.2M | 0.01% | −16,876−2.6% | Reduced |
| Franklin Resources Inc | 645,637 | $24.5M | 0.01% | +111,451+20.9% | Added |
| Royal Bank of Canada | 717,048 | $27.3M | 0.01% | +112,462+18.6% | Added |
| Stifel Financial Corp | 729,524 | $27.7M | 0.04% | −10,573−1.4% | Reduced |
| Renaissance Technologies LLC | 839,100 | $31.9M | 0.05% | −210,500−20.1% | Reduced |
| Bank of America Corp | 896,596 | $34.1M | 0.00% | −98,477−9.9% | Reduced |
| Morgan Stanley | 1,008,880 | $38.3M | 0.00% | −67,712−6.3% | Reduced |
| First Trust Advisors LP | 1,194,106 | $45.4M | 0.05% | −80,887−6.3% | Reduced |
| 1832 Asset Management L.P. | 2,243,600 | $85.3M | 0.17% | 00.0% | Unchanged |
| Wellington Management Group LLP | 2,417,137 | $91.9M | 0.02% | −3,783−0.2% | Reduced |
| Macquarie Group Ltd | 3,597,259 | $136.7M | 0.16% | +112,627+3.2% | Added |
| Capital International Investors | 4,197,060 | $157.2M | 0.04% | +88,355+2.2% | Added |
| BlackRock Inc. | 5,204,506 | $197.8M | 0.01% | −43,354−0.8% | Reduced |
| Alliancebernstein L.P. | 8,187,576 | $311.2M | 0.13% | +1,420,915+21.0% | Added |
| Arrowstreet Capital, Limited Partnership | 0 | $0 | 0.00% | −1,014,533−100.0% | Sold out |
| Capricorn Fund Managers Ltd | 0 | $0 | 0.00% | −110,643−100.0% | Sold out |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −106,291−100.0% | Sold out |
| Optiver Holding B.V. | 0 | $0 | 0.00% | −96,269−100.0% | Sold out |
| BI Asset Management Fondsmaeglerselskab A/S | 0 | $0 | 0.00% | −88,037−100.0% | Sold out |
| International Biotechnology Trust PLC | 0 | $0 | 0.00% | −88,000−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −80,264−100.0% | Sold out |
| XY Capital Ltd | 0 | $0 | 0.00% | −76,884−100.0% | Sold out |
| Mirabella Financial Services LLP | 0 | $0 | 0.00% | −28,260−100.0% | Sold out |
| First Republic Investment Management, Inc. | 0 | $0 | 0.00% | −57,309−100.0% | Sold out |
| Old Mission Capital LLC | 0 | $0 | 0.00% | −38,552−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −30,974−100.0% | Sold out |
| Seven Eight Capital, LP | 0 | $0 | 0.00% | −26,119−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −15,314−100.0% | Sold out |
| Integrated Investment Consultants, LLC | 0 | $0 | 0.00% | −13,738−100.0% | Sold out |
| FDx Advisors, Inc. | 0 | $0 | 0.00% | −10,976−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −10,947−100.0% | Sold out |
| D.A. Davidson & Co. | 0 | $0 | 0.00% | −6,710−100.0% | Sold out |
| Liberty Wealth Management LLC | 0 | $0 | 0.00% | −6,105−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −4,000−100.0% | Sold out |
| Belpointe Asset Management LLC | 0 | $0 | 0.00% | −2,186−100.0% | Sold out |
| Bokf, NA | 0 | $0 | 0.00% | −339−100.0% | Sold out |
| Sageworth Trust Co | 0 | $0 | 0.00% | −307−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −258−100.0% | Sold out |
| Cullen/Frost Bankers, Inc. | 0 | $0 | 0.00% | −186−100.0% | Sold out |
| Syverson Strege & Co | 0 | $0 | 0.00% | −177−100.0% | Sold out |
| Fortis Capital Advisors, LLC | 0 | $0 | 0.00% | −120−100.0% | Sold out |
| Schubert & Co | 0 | $0 | 0.00% | −83−100.0% | Sold out |
| Ameritas Advisory Services, LLC | 0 | $0 | 0.00% | −28−100.0% | Sold out |
| Baker Avenue Asset Management, LP | 0 | $0 | 0.00% | −21−100.0% | Sold out |
| Gradient Investments LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| McClarren Financial Advisors, Inc. | 0 | $0 | 0.00% | −3−100.0% | Sold out |